KR101844849B1 - composite composition containing hemp-seed oil and kenaf-seed oil and method for producing - Google Patents
composite composition containing hemp-seed oil and kenaf-seed oil and method for producing Download PDFInfo
- Publication number
- KR101844849B1 KR101844849B1 KR1020170095579A KR20170095579A KR101844849B1 KR 101844849 B1 KR101844849 B1 KR 101844849B1 KR 1020170095579 A KR1020170095579 A KR 1020170095579A KR 20170095579 A KR20170095579 A KR 20170095579A KR 101844849 B1 KR101844849 B1 KR 101844849B1
- Authority
- KR
- South Korea
- Prior art keywords
- seed oil
- kenaf
- hemp
- mixing
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000010460 hemp oil Substances 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 239000002131 composite material Substances 0.000 title claims description 24
- 239000003921 oil Substances 0.000 title abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 47
- 230000008569 process Effects 0.000 claims abstract description 38
- 238000002156 mixing Methods 0.000 claims abstract description 33
- 238000010438 heat treatment Methods 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 240000000249 Morus alba Species 0.000 claims abstract description 9
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 9
- 240000000797 Hibiscus cannabinus Species 0.000 claims description 85
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 69
- 239000004460 silage Substances 0.000 claims description 30
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 3
- 239000004065 semiconductor Substances 0.000 claims description 3
- 239000004927 clay Substances 0.000 claims 1
- 238000006386 neutralization reaction Methods 0.000 abstract description 13
- 239000000284 extract Substances 0.000 abstract description 9
- 229930014626 natural product Natural products 0.000 abstract description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 244000025254 Cannabis sativa Species 0.000 description 10
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 10
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 10
- 235000009120 camo Nutrition 0.000 description 10
- 235000005607 chanvre indien Nutrition 0.000 description 10
- 239000011487 hemp Substances 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- 230000001988 toxicity Effects 0.000 description 7
- 231100000419 toxicity Toxicity 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002519 immonomodulatory effect Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- -1 alumbuminide Substances 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960004365 benzoic acid Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000013462 Interleukin-12 Human genes 0.000 description 1
- 108010065805 Interleukin-12 Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000002509 fulvic acid Substances 0.000 description 1
- 229940095100 fulvic acid Drugs 0.000 description 1
- 229940098330 gamma linoleic acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940117681 interleukin-12 Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- YGSFNCRAZOCNDJ-UHFFFAOYSA-N propan-2-one Chemical compound CC(C)=O.CC(C)=O YGSFNCRAZOCNDJ-UHFFFAOYSA-N 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000006433 tumor necrosis factor production Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 및 그제조 방법에 관한 것으로 더욱 상세하게는 햄프씨드 오일, 케나프씨드 오일 및 실라짓을 일정한 비율로 혼합한 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 및 그 제조 방법에 관한 것이다.The present invention relates to a composite composition containing a hemp seed oil and a kenaf seed oil and a method of preparing the same, and more particularly, to a composite composition containing a hemp seed oil and a kenaf seed oil mixed with a certain ratio of hampton seed oil, kenaf seed oil, A seed oil, and a process for producing the same.
헴프씨드 오일은 헴프씨드를 저온에서 압착기를 통해 착유한 오일로서 필수 지방산, 비타민 A, D, E, 미네랄, 오메가 3, 6을 포함하고 있는 것으로 알려져 있다. 생선에서 추출한 오일을 제외하고 식물의 씨앗으로부터 오메가 3, 오메가 6을 함유하는 유일한 식물성 오일로 알려져 있다. 다른 식물성 오일 보다 많은 필수 지방산을 함유하는 것으로 오메가6, 오메가3의 비율이 3:1을 가지며, 천연 항산화제 비타민 E와 콜레스테롤의 흡수를 막는 스테롤이 함유되어 있다. Hemp seed oil is an oil that is milked through a presser at low temperature and contains essential fatty acids, vitamins A, D, E, minerals, omega 3, and 6. It is known as the only vegetable oil containing omega-3 and omega-6 from plant seeds, except for the oil extracted from fish. Containing more essential fatty acids than other vegetable oils, it has a 3: 1 ratio of omega-6 and omega-3 and contains sterols that prevent the absorption of natural antioxidant vitamin E and cholesterol.
또한, 헴프씨드 오일은 알파리놀레산(Alpha-Linolenic Acid; ALA)과 감마리놀레산이 풍부하여 사람의 피부 보습 및 피부를 부드럽게 하는 기능뿐만 아니라, 인, 칼륨, 마그네슘, 황, 칼슘과 철, 아연 등의 미네랄도 풍부하게 함유하고 있는 것으로 알려져 있다. In addition, Hemp seed oil is rich in Alpha-Linolenic Acid (ALA) and gamma linoleic acid, and is effective in moisturizing human skin and softening the skin, as well as being capable of supporting phosphorus, potassium, magnesium, sulfur, calcium, It is said to contain plenty of minerals.
이러한 헴프씨드 오일을 복용하면 인체의 콜레스테롤 농도를 낮추고, 혈관염증을 치료하며, 피를 맑게 하여 고혈압과 심장질환 및 발작을 감소시키는 기능으로도 작용한다. 특히, 피부에 바르게 되면 피부 보습을 유지하고, 피부 노화방지 및 피부재생 효과가 탁월하며, 아토피 피부에 사용하면 가려움증을 어느 정도 해소할 수 있는 작용을 한다. Taking these hemp seed oils also helps lower the body's cholesterol levels, treat vascular inflammation, and cleanse blood to reduce hypertension, heart disease and seizures. Especially, when applied to skin, it keeps skin moisturized, prevents aging of skin and exerts excellent effect on skin regeneration, and works to relieve itching to some extent when used on atopic skin.
케나프(kenaf)는 아열대 일년생 초본식물로써 우리나라에서는 오래전부터 양마라고 불렸다. 케나프는 기후와 토양에 대한 광범위한 적응성, 재배 용이성, 내 병충해성, 단위 면적당 높은 생산량과 짧은 생육기간, 생육기간이 길지 않음에도 빠른 성장에 따른 높은 탄소 고정성, 재생 가능성 그리고 생분해성 등에 있어서 매우 경제적인 식물로 알려져 있다.Kenaf (kenaf) is a subtropical annual herbaceous plant and has long been called a sheep in Korea. Kenaf has been widely used in the fields of climate and soil for a wide range of adaptability, ease of cultivation, resistance to insect pests, high production per unit area and short growth period, high carbon stability due to rapid growth, reproducibility and biodegradability It is known as an economical plant.
케나프 잎에는 칼슘이 다량 함유되어 있고, 다량의 단백질 비타민과 철분을 함유하고 있으며, 또한, 활성산의 작용을 막아주는 항산화 물질이 다량 함유되어 있어 인체에는 항암, 항바이러스, 항미생물, 항균, 항염 등으로 이용될 수 있으며, 또한, 인체에 유익한 성분들을 다량 함유하고 있어 앞으로도 이용가치가 매우 높은 식물이다.It contains a large amount of calcium, a large amount of protein vitamins and iron, and also contains a large amount of antioxidants that block the action of active acids. Therefore, the human body contains anticancer, antiviral, antimicrobial, It can be used for anti-inflammation and the like, and it is a plant having a very high utility value because it contains a large amount of components beneficial to human body.
종래에는 케나프 줄기와 잎을 건조하여 추출한 추출물과 이로부터 분리된 신규 캠프페롤 화합물 및 이의 식품으로의 용도가 개시되어 있으며, 항염증 및 면역조절 활성을 가지는 케나프 추출물 추출방법이나 추출물의 이용 등에 대해서는 개시되어 있으나, 항균활성을 촉진하는 케나프씨드 오일에 대해서는 기재되어 있지 않다.Conventionally, extracts obtained by drying and extracting kenaf stems and leaves, novel camperol compounds isolated therefrom, and uses thereof as food have been disclosed, and a method of extracting kenaf and extracts having anti-inflammatory and immunomodulating activity has been disclosed However, the kenaf seed oil for promoting the antibacterial activity is not described.
케나프씨드 오일은 칼슘, 철분 및 각종 비타민이 다량 함유되어 있어 복용하면 인체의 면역력 증강에 도움이 되는 것으로 알려져 있으며, 또한, 피부에 바르면 탁월한 효능이 있는 것으로 화장품의 원료로도 사용되고 있다.Kenaf seed oil is rich in calcium, iron and various vitamins. It is known that it helps improve the immunity of the human body. It is also used as a raw material for cosmetics because it has excellent efficacy when applied to the skin.
실라짓(shilajit)은 일명 mineral pitch로 알려져 있으며 하절기에 히말라야, 빈디야 등의 저산지대에 있는 바위에서 배출되는 자연적인 산출물이다. 실라짓은 점착성의 기질에 식물성 섬유와 미네랄이 포함된 식물성 유기물의 밀집체이며, 수분, 검류, 알부미노이드, 칼슘, 칼륨, 질소, 실리카, 수지, 식물질, 마그네슘, 황, 철, 염소, 인, 요오드, 글리코시드, 탄닌산, 벤조산, 비타민 및 효소를 포함하는 것으로 알려져 있다.Shilajit, also known as mineral pitch, is a natural product produced from rocks in low mountains such as the Himalayas and Binhdiya during the summer season. Silage is a compact of vegetable organic matter containing vegetable fibers and minerals in a sticky substrate and is a mixture of water, gum, alumbuminide, calcium, potassium, nitrogen, silica, resin, food, magnesium, sulfur, iron, , Iodine, glycoside, tannic acid, benzoic acid, vitamins and enzymes.
한편 실라짓은 전통적으로 히말라야 주변국들에서 전반적인 신체 기능 강화, 노화 방지, 혈당강하, 상처치유, 두뇌 기능강화, 골밀도 증가, 면역기능 강화, 관절염 및 고혈압 치료제 등으로 이용되어 왔다.In the Himalayas, it has traditionally been used in the countries of the Himalayas to strengthen the overall body function, prevent aging, reduce blood sugar, heal wounds, strengthen brain function, increase bone density, strengthen immune function, and treat arthritis and hypertension.
실라짓에 대해 좀 더 살펴보면, 수백만 년 전에 바다였었던 곳이 지각변동으로 해수면 밖으로 돌출되면서 퇴적되어 있던 플랑크톤 및 각종 영양소가 포함되어 덩어리가 된 것으로 히말라야 등의 저산지대에 있는 바위에서 배출되는 자연적인 산출물로서 검은 갈색의 끈적끈적한 액체이지만, 시장에서는 액상 또는 이를 건조하여 흑갈색의 고체상 물질로 유통되기도 한다.A more detailed look at the silage is that it was a mass of plankton and various nutrients that had been deposited as the sea had been extruded out of the sea by millions of years ago, It is dark brownish sticky liquid as an output, but it may be liquid or dried as a black brown solid material on the market.
미국특허 제6,440,436호에는 실라짓의 생활성 성분을 정제하는 방법이 개시되어 있으며, 이 방법으로 정제한 실라짓 추출물을 피부 보호 및 관리 제제로 이용하거나, 약학적 또는 영양학적 제제로 이용할 수 있음을 상술하고 있다. 상기 문헌에서 실리짓의 생리활성 성분은 0.3 중량%의 산소화된 디벤조-알파-피론(oxygenated dibenzo-α-pyrones)과 60 중량%의 저분자량의 풀벤산(fulvic acid)임이 밝혀졌다.U.S. Patent No. 6,440,436 discloses a method for purifying the bioactive component of silage, and the silage extract purified by this method can be used as a skin protection and management agent or as a pharmaceutical or nutritional preparation . In this document, the physiologically active ingredient of Seiljit was found to be 0.3 wt% oxygenated dibenzo-alpha-pyrones and 60 wt% low molecular weight fulvic acid.
특허문헌 1에 항염증 및 면역조절 활성을 가지는 케나프 추출물은 항염증 활성 및 면역조절 활성을 나타내는 케나프 추출물에 관한 것으로서, 염증반응인자로서의 종양괴사인자-α 생성 억제, 인터류킨-3 및 인터류킨-12의 mRNA 발현 억제, 산화질소 및 프로스타글란딘, 활성산소종의 생성을 억제하여 면역조절에 관여하는 대식세포의 기능을 조절하는 효과를 가지고 있어 면역반응에 의한 질환의 예방 및 치료에 유용한 케나프 추출물에 관한 기술이 개시되어 있다. The kenaf extract having anti-inflammatory and immunomodulating activity in Patent Document 1 relates to a kenaf extract exhibiting anti-inflammatory activity and immunoregulatory activity, and is useful as an inhibitor of tumor necrosis factor-α production as an inflammatory reaction factor, an interleukin- 12 mRNA expression inhibition, nitric oxide and prostaglandin, and the production of reactive oxygen species, thereby controlling the function of macrophages involved in immune regulation. Thus, the present invention is useful for the prevention and treatment of diseases caused by immune response Is disclosed.
그러나 특허문헌 1의 항염증 및 면역조절 활성을 가지는 케나프 추출물은 케나프의 줄기를 건조하여 단일 또는 2종 이상의 혼합 용매를 혼합하여 침지시킨 후 추출하여 추출원액을 여과 및 농축시켜 얻어진 케나프 추출물만을 이용하는 것으로 헴프씨드 오일과 케나프씨드 오일 및 중화과정을 거친 실라짓을 일정한 비율로 혼합한 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 및 그 제조 방법에 대해서는 전혀 개시하지 못하고 있다.However, the kenaf extract having the anti-inflammatory and immunomodulating activity of Patent Document 1 can be prepared by drying the kenaf stems and mixing the single or two or more mixed solvents and immersing them, extracting the kenaf extract, The present invention discloses a composite composition containing hemp seed oil and kenaf seed oil obtained by mixing hemp seed oil and kenaf seed oil and neutralized silica powder at a certain ratio and a method for producing the same.
특허문헌 2는 케나프로부터 분리된 항균 활성능을 가지는 기능성 식품에 관한 것으로 케나프 잎에서 메탄올로 추출하여 메탄올 조추출물을 수득하는 단계; 상기 메탄올 조추출물을 물, 지방족 알코올, 알코올 수용액, 헥산, 클로로포름, 에틸아세테이트, 벤젠 및 부탄올 중에서 선택된 용매로 추출하여 물층 및 유기층을 수득하는 단계; 상기 물층 및 유기층을 순상 실리카 크로마토그래피 컬럼에 흡착시킨 후, 톨루엔, 아세톤 및 메탄올 혼합물의 비율을 톨루엔과 아세톤 및 아세톤과 메탄올의 비율을 변화시키면서 용출시켜, 항균 및 항산화 활성이 확인된 분획들(톨루엔 : 아세톤 아세톤과 메탄올)을 수득하는 단계; 상기 분획을 2차 순상 실리카 크로마토그래피 컬럼에 흡착시킨 후, 물과 메탄올 10 : 0∼5 : 5의 비율로 변화시키면서 용출시켜 활성 분획을 수득하는 단계; 상기 분획을 40 %메탄올을 용매를 사용하여 겔 필터 크로마토그래피를 실시하여 정제하는 단계; 상기 정제된 분획을 최종적으로 재결정 방법 및 고속 액체크로마토그래피를 이용하여 단일 활성 화합물을 정제하는 단계를 포함하여 이루어지는 방법에 관한 기술이 개시되어 있다.Patent Document 2 relates to a functional food having antimicrobial activity performance separated from kenafro, which comprises extracting methanol extract from kenaf leaves with methanol, Extracting the methanol crude extract with water, an aliphatic alcohol, an aqueous alcohol solution, a solvent selected from hexane, chloroform, ethyl acetate, benzene and butanol to obtain an aqueous layer and an organic layer; After the water layer and the organic layer were adsorbed on a normal silica gel column, the toluene, acetone and methanol mixture ratios were eluted with varying ratios of toluene, acetone, acetone and methanol to obtain antimicrobial and anti- : Acetone acetone and methanol); Adsorbing the fraction to a secondary normal phase silica chromatography column, eluting the mixture with water and methanol at a ratio of 10: 0 to 5: 5 to obtain an active fraction; Purifying said fraction by performing gel filtration chromatography using 40% methanol as a solvent; And finally purifying the purified fraction using a recrystallization method and high-performance liquid chromatography to purify the single active compound.
그러나 특허문헌 2의 케나프로부터 분리된 항균 활성능을 가지는 기능성 식품에는 헴프씨드 오일과 케나프씨드 오일 및 중화과정을 거친 실라짓을 일정한 비율로 혼합한 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 및 그 제조 방법에 대해서는 전혀 개시하지 못하고 있다.However, the functional food having antimicrobial activity performance separated from Kenafro of Patent Document 2 includes Hemp seed oil and Kenaf seed oil, and Hemp seed oil and Kenaf seed oil obtained by mixing silage with neutralization process at a certain ratio The composite composition and the manufacturing method thereof have not been disclosed at all.
상기의 문제점을 해결하고자 본 발명은 햄프씨드 오일과 케나프씨드 오일을 일정한 비율로 혼합한 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물을 제공하고자 한다. In order to solve the above problems, the present invention provides a composite composition comprising a mixture of hampton seed oil and kenaf seed oil at a certain ratio, and a kenaf seed oil.
또한, 상기의 문제점을 해결하고자 본 발명은 헴프씨드 오일과 케나프씨드 오일 및 중화과정을 거친 실라짓을 일정한 비율로 혼합한 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물을 제공하고자 한다. In order to solve the above problems, the present invention provides a composite composition comprising hemp seed oil and kenaf seed oil obtained by mixing hemp seed oil, kenaf seed oil, and neutralized silazil with a certain ratio.
또한, 상기의 문제점을 해결하고자 본 발명은 헴프씨드 오일과 케나프씨드 오일을 일정한 비율로 혼합한 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 제조 방법을 제공하고자 한다.In order to solve the above problems, the present invention provides a method for producing a composite composition containing a hemp seed oil and kenaf seed oil obtained by mixing a hemp seed oil and a kenaf seed oil at a predetermined ratio.
또한, 상기의 문제점을 해결하고자 본 발명은 헴프씨드 오일과 케나프씨드 오일 및 중화과정을 거친 실라짓을 일정한 비율로 혼합한 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 제조 방법을 제공하고자 한다. In order to solve the above problems, the present invention provides a method for producing a composite composition containing a hemp seed oil and a kenaf seed oil obtained by mixing a hemp seed oil, a kenaf seed oil and a neutralized silazet at a predetermined ratio do.
상기의 해결하는 과제를 위한 본 발명에 따른 복합 조성물은 헴프씨드 오일 50∼60 중량%와 케나프씨드 오일 40∼50 중량%로 혼합한 것이 특징이다.The composite composition according to the present invention for solving the above problem is characterized in that 50 to 60 wt% of hemp seed oil and 40 to 50 wt% of kenaf seed oil are mixed.
본 발명의 일실시예로서, 본 발명에 따른 복합 조성물은 헴프씨드 오일 40∼60 중량%, 케나프씨드 오일 30∼50 중량% 및 중화과정을 거친 실라짓 5∼15 중량%로 혼합한 것이 특징이다.According to one embodiment of the present invention, the composite composition according to the present invention is prepared by mixing 40 to 60 wt% of hemp seed oil, 30 to 50 wt% of kenaf seed oil, and 5 to 15 wt% of silazed through neutralization to be.
본 발명의 일실시예로서, 본 발명에 따른 복합 조성물 제조 방법은 헴프씨드 오일 및 케나프씨드 오일을 준비하는 단계; 상기 헴프씨드 오일 50∼60 중량%와 케나프씨드 오일 40∼50 중량%로 혼합하는 단계를 포함하고, 상기 혼합하는 단계는 상기 햄프씨드 오일 및 케나프씨드 오일을 각각 40∼50℃에서 혼합하여 20∼40분간 교반하는 단계를 포함하는 것이 특징이다.According to one embodiment of the present invention, a method for preparing a composite composition according to the present invention comprises the steps of: preparing a hemp seed oil and a kenaf seed oil; Mixing the hemp seed oil and the kenaf seed oil in an amount of 50 to 60% by weight and kenaf seed oil in an amount of 40 to 50% by weight, wherein the mixing step comprises mixing the hampton seed oil and the kenaf seed oil at 40 to 50 ° C Followed by stirring for 20 to 40 minutes.
본 발명의 일실시예로서, 본 발명에 따른 복합 조성물 제조 방법은 헴프씨드 오일, 케나프씨드 오일 및 중화과정을 거친 실라짓을 준비하는 단계; 상기 헴프씨드 오일 40∼60 중량%, 케나프씨드 오일 30∼50 중량% 및 실라짓 5∼15 중량%로 혼합하는 단계를 포함하고, 상기 혼합하는 단계는 상기 햄프씨드 오일, 케나프씨드 오일 및 실라짓을 각각 40∼50℃에서 혼합하여 20∼40분간 교반하는 단계를 포함하는 것이 특징이다.In one embodiment of the present invention, a method for preparing a composite composition according to the present invention comprises the steps of: preparing hemp seed oil, kenaf seed oil, and neutralized silica powder; Wherein the mixing step comprises mixing the rapeseed oil with 40 to 60 wt% of the hemp seed oil, 30 to 50 wt% of the kenaf seed oil, and 5 to 15 wt% of the silage, wherein the mixing step comprises mixing the hampton seed oil, And mixing the slurry with each other at 40 to 50 캜 and stirring for 20 to 40 minutes.
본 발명의 일실시예로서, 상기 중화과정은 물 40∼60 중량%에 분쇄된 뽕잎 40∼60 중량%를 혼합하여 70∼80℃로 4∼6시간 동안 가열한 농축물과 자연적 산출물인 실라짓을 각각 40∼50℃에서 동일한 중량%의 비율로 혼합하는 단계를 포함하는 것이 특징이다.In an embodiment of the present invention, the neutralization process comprises mixing 40 to 60% by weight of mulberry leaves pulverized to 40 to 60% by weight of water, concentrating the mixture at 70 to 80 DEG C for 4 to 6 hours, At a ratio of the same weight% at 40 to 50 DEG C, respectively.
본 발명의 복합 조성물을 피부에 바르게 되면, 피부의 외상이나 피부염증을 빠르게 회복시켜주고, 피부 건조증 완화에도 도움이 되며, 또한 아토피, 대상포진 등 피부과적 원상회복에 도움을 주는 효과가 있다.When the composite composition of the present invention is applied to the skin, it quickly restores the skin trauma and inflammation of the skin, helps alleviate the dryness of the skin, and also has an effect of helping recovery of dermatological conditions such as atopy and shingles.
본 발명의 복합 조성물을 복용하게 되면, 불포화 지방산이 다량 함유되어 있어 노화 방지에 도움이 되며, 인체의 콜레스테롤 농도를 낮추고, 세포 활성화를 촉진시켜 면역력을 강화시키고 심혈관 질환의 원인이 되는 혈전을 분해함으로써 혈액순환을 촉진시키는 효과가 있다.When the complex composition of the present invention is used, it contains a large amount of unsaturated fatty acids, which helps prevent aging. It lowers the cholesterol concentration of the human body, accelerates cell activation, strengthens immunity, decomposes thrombi which is a cause of cardiovascular disease It has the effect of promoting blood circulation.
도 1은 본 발명의 일실시예에 따른 헴프씨드 오일 착유과정을 도시한 예이다.
도 2는 본 발명의 일실시예에 따른 케나프씨드 오일 착유과정을 도시한 예이다.
도 3은 본 발명의 일실시예에 따른 자연적 산출물인 실라짓의 독성을 제거하는 중화과정을 도시한 예이다.
도 4는 본 발명의 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 생성과정을 도시한 예이다.
도 5 및 도 6은 본 발명의 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 제조 방법을 도시한 예이다.FIG. 1 is an illustration showing a process of milking hemp seed oil according to an embodiment of the present invention.
FIG. 2 shows an example of a kenaf seed oiling process according to an embodiment of the present invention.
FIG. 3 is an example of a neutralization process for eliminating the toxicity of silage, which is a natural product according to an embodiment of the present invention.
FIG. 4 is a view showing a process of producing a composite composition containing the hemp seed oil and kenaf seed oil of the present invention.
Figs. 5 and 6 show an example of a method for producing a composite composition containing the hemp seed oil and the kenaf seed oil of the present invention.
이하, 본 발명의 실시를 위한 구체적인 실시예를 도면을 참고하여 설명한다. 본 발명의 실시예는 하나의 발명을 설명하기 위한 것으로서 권리범위는 예시된 실시예에 한정되지 아니하고, 예시된 도면은 발명의 명확성을 위하여 핵심적인 내용만 확대 도시하고 부수적인 것을 생략하였으므로 도면에 한정하여 해석하여서는 아니 된다.DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, embodiments of the present invention will be described with reference to the drawings. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are not intended to limit the invention to the particular forms disclosed. And shall not interpret it.
도 1을 참조하여 본 발명의 실시예에 의한 헴프씨드 오일 착유과정에 대해 보다 구체적으로 설명하도록 한다.The process of milking the hemp seed oil according to the embodiment of the present invention will be described in more detail with reference to FIG.
본 발명에 따른 헴프씨드 오일 착유과정은 헴프씨드의 껍질을 제거하는 과정과 껍질이 제거된 헴프씨드를 착유기에 넣고 압착하여 헴프씨드 오일을 생성하는 과정으로 이루어진다. The process of milking the hemp seed oil according to the present invention comprises a step of removing the shell of the hemp seed and a step of putting the shell-removed hemp seed into the milking machine and pressing the hemp seed oil to produce the hemp seed oil.
상기 헴프씨드의 껍질을 제거하는 과정은 헴프씨드의 껍질을 도정기와 같은 껍질을 벗겨낼 수 있는 장치를 이용하여 벗겨내야 하는데, 그 이유는 헴프씨드 껍질에 함유된 마약성분과 인체에 해로운 성분을 제거하기 위함이다.In the process of removing the bark of the hemp seed, the bark of the hemp seed must be peeled off using a device capable of peeling the bark like a pottery, because the drug ingredient contained in the hemp seed bark and the harmful component .
이렇게 껍질을 벗김으로써 마약성분과 인체에 해로운 성분이 제거된 헴프씨드는 고혈압, 고지혈증, 동맥 경화 및 당뇨, 항암 효과가 있는 것으로 알려져 있으며, 이 외에도 혈압을 낮추는 데에도 도움이 되며, 불포화 지방산이 다량 함유되어 있어 노화를 방지할 뿐만 아니라, 혈액순환을 촉진하고 변비 및 피부 건조증 완화에도 효과적인 것으로 알려져 있다.Hemp seeds have been shown to have antihypertensive, hyperlipidemic, atherosclerotic and diabetic, anticancer effects, as well as help lower blood pressure, and have a large amount of unsaturated fatty acids And is known to be effective not only to prevent aging but also to promote blood circulation and alleviate constipation and dry skin.
상기 헴프씨드 오일 착유과정은 상기 껍질이 제거된 헴프씨드를 착유기에 넣고 헴프씨드를 압착하여 오일을 추출하는 과정으로 이때, 헴프씨드에 함유된 인체에 유효한 성분의 파괴를 최소화하기 위해 착유전이나 착유과정에서 고온 열처리를 진행하지 않아야 하며, 온도는 40℃∼50℃를 유지시켜 진행하는 것이 특징이다.The process for milking the hemp seed oil is a process for extracting the oil by extracting the husked hemp seed into the milking machine and pressing the hemp seed to minimize the destruction of the effective ingredient in the human body contained in the hemp seed. It is not necessary to carry out the heat treatment at a high temperature and it is characterized in that the temperature is maintained at 40 ° C to 50 ° C.
상기 착유기를 통한 착유과정에서 착유기 외함에 반도체 냉각방식을 적용하여 40℃∼50℃로 유지시키는 것이 특징이다.And the semiconductor cooling method is applied to the milking machine enclosure during the milking process through the milking machine to maintain the temperature of the milking machine at 40 ° C to 50 ° C.
상기 착유과정에서 40℃ 미만에서 착유를 진행하게 되면, 헴프씨드에 함유된 인체에 유효한 성분의 추출 효율성이 현저히 저하될 수 있으며, 상기 착유과정에서 70℃를 초과하여 착유를 진행하게 되면 헴프씨드에 함유되어 있는 인체에 유효한 성분이 파괴될 수 있다.If milking is carried out at a temperature lower than 40 ° C during the milking process, the extraction efficiency of a component effective for the human body contained in the hemp seed may be significantly lowered. If the milking process exceeds 70 ° C during the milking process, The active ingredient in the human body contained therein may be destroyed.
도 2는 본 발명의 일실시예에 따른 케나프씨드 오일 착유과정을 도시한 예이다. FIG. 2 shows an example of a kenaf seed oiling process according to an embodiment of the present invention.
도 2를 참조하여, 본 발명의 일실시예에 따른 케나프씨드 오일 착유과정에 대해 상세히 설명하기로 한다.Referring to FIG. 2, a kenaf seed oil-feeding process according to an embodiment of the present invention will be described in detail.
케나프씨드는 인체에 유효한 성분을 다량 함유하고 있는데, 케나프 잎의 성분에는 다량의 칼슘 및 단백질, 비타민과 철분을 함유하고 있으며, 또한 활성산의 작용을 막아주는 항산화 물질이 다량 함유되어 있어 인체에는 항암, 항바이러스, 항미생물, 항균, 항염 등으로 이용될 수 있으며, 또한 이러한 효능을 바탕으로 이용가치가 매우 높은 식물로 주로 케나프 줄기와 잎을 건조하여 추출한 추출물과 이로부터 분리된 신규 캠프페롤 화합물 및 이의 식품으로 첨가하여 이용하거나, 항염증 및 면역조절 활성을 가지는 케나프 추출물을 이용하는 것으로 알려져 있다.The kenaf seed contains a large amount of active ingredients in the body. The kenaf leaf contains a large amount of calcium and protein, vitamins and iron, and also contains a large amount of antioxidants that block the activity of active acids. Is a plant with high utilization value and can be used for anticancer, antiviral, antimicrobial, antibacterial, anti-inflammation, etc. Based on these effects, it is mainly extracted from kenaf stems and leaves, Ferulic compound and its food, or it is known to use kenaf extract having anti-inflammatory and immunomodulating activity.
본 발명의 실라짓을 함유하는 복합 조성물은 케나프의 줄기나 잎을 사용하는 것이 아니라 케나프씨드에 다량 함유된 인체에 유효한 성분을 추출한 케나프씨드 오일을 사용하는 것이 특징이다. The composite composition containing silazimate of the present invention is characterized not by using the stem or leaf of kenaf but by using kenaf seed oil extracted from the effective ingredient in human body which is contained in large amount in kenaf seed.
본 발명에 따른 케나프씨드 오일 착유과정은 케나프씨드의 껍질을 제거하거나 볶음과정 없이 케나프씨드를 착유기에 넣고 압착을 통해 케나프씨드 오일을 착유하는 과정으로 이루어진다. The process of milking the kenaf seed oil according to the present invention comprises a step of milking the kenaf seed oil by pressing the kenaf seed into the milking machine without removing the shell of the kenaf seed or roasting.
상기 케나프씨드 오일 착유과정은 상기 볶음이나 껍질이 제거되지 않은 케나프씨드를 착유기에 넣고 압착하여 오일을 추출하는 과정으로 이때, 케나프씨드에 함유된 인체에 유효한 성분의 파괴를 최소화하기 위해, 착유전이나 착유과정에서 고온 열처리를 진행하지 않으면서 40℃∼50℃를 유지시켜 진행하는 것이 특징이다.The kenaf seed oil-milking process is a process for extracting oil by kneading the kenaf seed without the roasted or peel-removed kenaf seeds in a milking machine. In order to minimize destruction of the effective ingredient in the kenaf seed, It is characterized in that it is maintained at 40 ° C to 50 ° C without advancing the high temperature heat treatment before milking or milking.
상기 착유기를 통한 착유과정에서 착유기 외함에 반도체 냉각방식을 적용하여 40℃∼50℃로 유지시키는 것이 특징이다.And the semiconductor cooling method is applied to the milking machine enclosure during the milking process through the milking machine to maintain the temperature of the milking machine at 40 ° C to 50 ° C.
상기 착유과정에서 40℃ 미만에서 진행하게 되면, 케나프씨드에 함유된 인체에 유효한 성분의 추출 효율성이 현저히 저하될 수 있으며, 상기 착유과정에서 70℃를 초과하여 착유를 진행하게 되면 케나프씨드에 함유되어 있는 인체에 유효한 성분이 파괴될 수 있다. If the temperature is lower than 40 ° C during the milking process, the extraction efficiency of a component effective in the human body contained in the kenaf seed may be significantly lowered. If the milking process exceeds 70 ° C during the milking process, The active ingredient in the human body contained therein may be destroyed.
도 3은 본 발명의 일실시예에 따른 자연적 산출물인 실라짓의 독성을 제거하는 중화과정을 도시한 예이다.FIG. 3 is an example of a neutralization process for eliminating the toxicity of silage, which is a natural product according to an embodiment of the present invention.
상기 실라짓은 일명 mineral pitch로 알려져 있으며 하절기에 히말라야, 빈디야 등의 저산지대에 있는 바위에서 배출되는 자연적인 산출물이다. 상기 실라짓은 점착성의 기질에 식물성 섬유와 미네랄이 포함된 식물성 유기물의 밀집체이며, 수분, 검류, 알부미노이드, 칼슘, 칼륨, 질소, 실리카, 수지, 식물질, 마그네슘, 황, 철, 염소, 인, 요오드, 글리코시드, 탄닌산, 벤조산, 비타민 및 효소를 포함하는 것으로 알려져 있다. 상기 실라짓은 전통적으로 히말라야 주변국들에서 전반적인 신체 기능 강화, 노화 방지, 혈당강하, 상처치유, 두뇌 기능강화, 골밀도 증가, 면역기능 강화, 관절염 및 고혈압 치료제 등으로 이용되어져 왔다.The silage is known as the mineral pitch and is a natural product of rocks in low mountains such as Himalaya and Binhdiya during the summer season. The silage is a compact of vegetable organic material containing vegetable fibers and minerals in a sticky substrate and may be in the form of water, gums, alumbuminoids, calcium, potassium, nitrogen, silica, resins, substances, magnesium, Phosphorous, iodine, glycoside, tannic acid, benzoic acid, vitamins and enzymes. Traditionally, in the Himalayan countries, the silage has been used in the Himalayan countries as a whole to strengthen the body functions, to prevent aging, to reduce blood sugar, to heal wounds, to strengthen brain function, to increase bone density, to strengthen immune function, and to treat arthritis and hypertension.
상기 실라짓의 주성분은 아미노산 및 미네랄 성분으로 이루어져 있어, 인간의 몸 밖에서 생성되어진 아미노산은 몸 안에서 대사과정을 거치지 않은 생성된 물질로 인체에 해로운 독성을 함유하고 있어 독성을 제거하는 중화과정을 반드시 거쳐야만 안정된 물질로 변화되는 특성을 가지고 있다.Since the main component of the silage is composed of amino acids and minerals, the amino acids produced outside the human body contain toxic substances harmful to the human body, which are not produced through metabolic processes in the body and must be neutralized to remove the toxicity It has a characteristic that it changes into a stable substance.
따라서 자연적 산출물인 실라짓은 독성을 제거하는 중화과정을 거치지 않으면 인체에 해로운 독성을 포함하고 있기 때문에 독성을 제거하는 중화과정이 반드시 필요하다. Therefore, it is necessary to neutralize silage which is a natural product, because it contains harmful toxicity to the human body, if it does not go through the neutralization process to remove the toxicity.
상기 자연적 산출물인 실라짓의 독성을 제거하는 중화과정에 대해 자세하게 설명해보면, 물 40∼60 중량%에 분쇄된 뽕잎 40∼60 중량%를 잘 섞어 혼합한 다음 70∼80℃로 4∼6시간 동안 가열하여 농축물을 생성한다. 상기 농축물 생성과정에서 가열시간이 6시간을 초과하거나 가열온도가 80℃를 초과하게 되면 분쇄된 뽕잎에 함유되어 있는 인체에 유효한 기능성 성분들이 파괴될 수 있으므로 주의해야 한다. 또한, 가열시간이 4시간 미만이거나 가열온도가 70℃ 미만이면 분쇄된 뽕잎에 함유되어 있는 인체에 유효한 기능성 성분들을 추출할 수 없으므로 주의해야 한다.To neutralize the toxicity of silage, which is a natural product, in detail, 40 to 60% by weight of water is mixed with 40 to 60% by weight of ground mulberry leaves and mixed at 70 to 80 ° C for 4 to 6 hours The concentrate is produced by heating. If the heating time exceeds 6 hours or the heating temperature exceeds 80 ° C in the process of producing the concentrate, the functional ingredients effective in the human body contained in the pulverized mulberry leaves may be destroyed. If the heating time is less than 4 hours or the heating temperature is lower than 70 캜, it is impossible to extract effective functional ingredients contained in the pulverized mulberry leaves.
상기 생성된 농축물과 자연적 산출물인 실라짓을 혼합하는 중화과정에 있어서, 상기 농축물 및 실라짓은 수성이므로 각각 40∼50℃에서 동일한 중량%의 비율로 혼합함으로써 독성이 제거된 실라짓을 생성할 수 있다. In the neutralization process in which the resulting concentrate is mixed with silage, which is a natural product, the concentrate and silage are aqueous, so that they are mixed at the same weight percentages at 40 to 50 ° C to produce silage without toxicity .
도 4를 참조하여 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 생성과정에 대해 보다 구체적으로 설명하도록 한다.The production process of the composite composition containing the hemp seed oil and the kenaf seed oil will be described in more detail with reference to FIG.
도 4를 참조하면, 헴프씨드 오일과 케나프씨드 오일을 준비하고 중화과정을 거친 실라짓을 준비한 다음, 헴프씨드 오일과 케나프씨드 오일 및 중화과정을 거친 실라짓을 일정한 비율로 혼합하는 과정을 거치게 된다.Referring to FIG. 4, hemp seed oil and kenaf seed oil were prepared, neutralized silica powder was prepared, and then hemp seed oil, kenaf seed oil and neutralized silica powder were mixed at a predetermined ratio .
상기 일정한 혼합비율에 대해 보다 구체적으로 설명해보면, 헴프씨드 오일 40∼60 중량%, 케나프씨드 오일 30∼50 중량% 및 중화과정을 거친 실라짓 5∼15 중량%의 조성비로 혼합될 수 있다. More specifically, the mixing ratio may be in the range of 40 to 60 wt% of hemp seed oil, 30 to 50 wt% of kenaf seed oil, and 5 to 15 wt% of silage after neutralization.
상기 조성비에서 헴프씨드 오일이 60 중량%를 초과하게 되면 헴프씨드 오일은 수용성이고 케나프씨드 오일은 지용성으로 40∼50℃에서 혼합하더라도 화학적으로 완전한 혼합이 되지 않기 때문에 시간이 경과되면 층이 분리되는 현상이 나타날 수 있다. 또한, 헴프씨드 오일이 40 중량% 미만이면 헴프씨드 오일에 함유되어 있는 특정한 약용 성분의 불균형으로 인하여 인체에 유익한 성분들이 부족하여 효능이 저하될 수 있다.When the hemp seed oil is more than 60% by weight in the composition ratio, the hemp seed oil is water-soluble and the kenaf seed oil is fat-soluble. Even when the hemp seed oil is mixed at 40 to 50 캜, A phenomenon may occur. If the amount of the hemp seed oil is less than 40% by weight, an unbalance of a specific medicinal ingredient contained in the hemp seed oil may result in a lack of useful components for the human body, which may deteriorate the efficacy.
또한 상기 조성비에서 케나프씨드 오일이 50 중량%를 초과하게 되면 헴프씨드 오일은 수용성이고 케나프씨드 오일은 지용성으로 40∼50℃에서 혼합하더라도 화학적으로 완전한 혼합이 되지 않기 때문에 시간이 경과되면 층이 분리되는 현상이 나타날 수 있다. 또한 케나프씨드 오일이 30 중량% 미만이면 케나프씨드 오일에 함유되어 있는 특정한 약용 성분의 불균형으로 인하여 인체에 유익한 성분들이 부족하여 효능이 저하될 수 있다.When the kenaf seed oil is more than 50% by weight in the composition ratio, the hemp seed oil is water-soluble and the kenaf seed oil is oil-soluble. Even if the oil is mixed at 40 to 50 캜, Separation may occur. In addition, if the kenaf seed oil is less than 30% by weight, the unfavorable constituents of the specific medicinal ingredients contained in the kenaf seed oil may be detrimental to the human body, resulting in deteriorated efficacy.
또한, 상기 조성비에서 중화과정을 거친 실라짓이 15 중량%를 초과하게 되면 상기 실라짓에 함유되어 있는 특정한 약용 성분이 과다하여 사람이 복용하게 되면, 졸림 현상을 유발할 수 있다. 또한 상기 실라짓이 5 중량% 미만이면 인체에 유익한 특정한 약용 성분이 저하될 수 있으며, 헴프씨드 오일 및 케나프씨드 오일과 혼합 시 불완전 혼합으로 층 분리현상이 일어날 수 있다.In addition, if the amount of silage that has undergone the neutralization process exceeds 15% by weight, the specific medicinal ingredient contained in the silage may be too much, which may cause drowsiness. If the silage content is less than 5% by weight, a certain medicinal component beneficial to the human body may be deteriorated. When the hemp seed oil and the kenaf seed oil are mixed with each other, incomplete mixing may occur.
상기 혼합과정에서 헴프씨드 오일과 케나프씨드 오일을 먼저 혼합하여 교반한 후에 중화과정을 거친 실라짓을 혼합하여 교반하여야 되는데, 수성인 헴프씨드 오일 및 케나프씨드 오일과 수성인 중화과정을 거친 실라짓이 화학적으로 혼합될 수 있도록 햄프씨드 오일, 케나프씨드 오일 및 중화과정을 거친 실라짓을 각각 40∼50℃에서 혼합하여 20∼40분간 교반하는 것이 특징이다.In the mixing process, the hemp seed oil and the kenaf seed oil are first mixed and stirred, and then the neutralized silazet is mixed and stirred. The aqueous hemp seed oil and the kenaf seed oil are mixed with the silane In order to chemically mix the dough, the hampad seed oil, the kenaf seed oil and the neutralized silage are mixed at 40 to 50 ° C and stirred for 20 to 40 minutes.
다만, 70℃ 이상에서 혼합하게 되면 헴프씨드 오일, 케나프씨드 오일 및 중화과정을 거친 실라짓에 함유된 인체에 유효한 기능성 성분들이 파괴될 수 있으므로 주의해야 한다.However, caution should be exercised when mixing at a temperature above 70 ° C, since the functional ingredients effective in the human body contained in the hemp seed oil, the kenaf seed oil and the neutralized silage may be destroyed.
상기 헴프씨드 오일, 케나프씨드 오일 및 중화과정을 거친 실라짓을 각각 40∼50℃에서 혼합하여 20∼40분간 혼합과정을 거친 혼합물은 세그먼트 필터를 통해 여과과정을 거치고, 자연 냉각시킴으로서 복합 조성물을 완성하게 되는데 맑은 갈색의 실라짓을 함유하는 복합 조성물이 생성된다.The hemp seed oil, the kenaf seed oil and the neutralized silage were mixed at 40 to 50 ° C, and the mixture was subjected to a mixing process for 20 to 40 minutes. The mixture was filtered through a segment filter, And a composite composition containing clear brown silage is produced.
도 5 및 도 6을 참조하여, 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 제조 방법에 대해 보다 구체적으로 설명하도록 한다.5 and 6, a method for producing a composite composition containing hemp seed oil and kenaf seed oil will be described in more detail.
헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 제조 방법에 있어서, 헴프씨드 오일 및 케나프씨드 오일을 준비하여 상기 헴프씨드 오일 50∼60 중량%와 케나프씨드 오일 40∼50 중량%로 혼합한다. 혼합하는 과정은 상기 햄프씨드 오일 및 케나프씨드 오일을 각각 40∼50℃에서 혼합하여 20∼40분간 교반하는 단계를 포함하는 것이 특징이다.A method for producing a composite composition containing a hemp seed oil and a kenaf seed oil, comprising the steps of: preparing a hemp seed oil and a kenaf seed oil; mixing the hemp seed oil and the kenaf seed oil in an amount of 50 to 60 wt% do. The mixing step comprises mixing the hampton seed oil and the kenaf seed oil at 40 to 50 ° C and stirring for 20 to 40 minutes.
또한, 헴프씨드 오일과 케나프씨드 오일을 함유하는 복합 조성물 제조 방법에 있어서, 헴프씨드 오일, 케나프씨드 오일 및 중화과정을 거친 실라짓을 준비하여 상기 헴프씨드 오일 40∼60 중량%, 케나프씨드 오일 30∼50 중량% 및 실라짓 5∼15 중량%로 혼합한다. 혼합하는 과정은 상기 햄프씨드 오일, 케나프씨드 오일 및 실라짓을 각각 40∼50℃에서 혼합하여 20∼40분간 교반하는 단계를 포함하는 것이 특징이다.Further, in the method for producing the composite composition containing the hemp seed oil and the kenaf seed oil, the hemp seed oil, the kenaf seed oil and the neutralized silazil are prepared, and the hemp seed oil is contained in an amount of 40 to 60 wt% 30 to 50% by weight of seed oil and 5 to 15% by weight of silage. The mixing process comprises mixing the ham's seed oil, kenaf seed oil and silage at 40 to 50 DEG C and stirring for 20 to 40 minutes.
상기 중화과정은 물 40∼60 중량%에 분쇄된 뽕잎 40∼60 중량%를 혼합하여 70∼80℃로 4∼6시간 동안 가열한 농축물과 자연적 산출물인 실라짓을 각각 40∼50℃에서 동일한 중량%의 비율로 혼합하는 단계를 포함하는 것이 특징이다.The neutralization process is carried out by mixing 40 to 60% by weight of mulberry leaves with 40 to 60% by weight of water, heating the mixture at 70 to 80 DEG C for 4 to 6 hours and the natural product, silage, at 40 to 50 DEG C By weight based on the total weight of the composition.
물론, 통상의 기술자라면 상기 헴프씨드 오일과 케나프씨드 오일 및 중화과정을 거친 실라짓의 혼합비를 조절하여 새로운 복합 조성물을 생성할 수 있을 것이다.Of course, a conventional artisan will be able to produce a new composite composition by controlling the mixing ratio of the hemp seed oil, the kenaf seed oil, and the silage which has undergone the neutralization process.
Claims (5)
물 40∼60 중량%에 분쇄된 뽕잎 40∼60 중량%를 혼합하여 70∼80℃로 4∼6시간 동안 가열하여 뽕잎 농축물을 준비하는 단계;
헴프씨드 오일, 케나프씨드 오일 및 히말라야산 실라짓을 준비하는 단계;
상기 뽕잎 농축물과 히말라야산 실라짓을 40∼50℃에서 동일한 중량%의 비율로 혼합하여 중화하는 단계 및
상기 헴프씨드 오일 40∼60 중량%, 케나프씨드 오일 30∼50 중량% 및 중화과정을 거친 히말라야산 실라짓 5∼15 중량%로 혼합하여 40∼50℃에서 혼합하여 20∼40분간 교반하는 단계를 포함하되,
상기 헴프씨드 오일 및 케나프씨드 오일의 착유과정은 착유기 외함에 반도체 냉각방식을 적용하여 40∼50℃를 유지시켜 진행하는 것을 특징으로 하는 복합 조성물 제조 방법.A method for producing a composite composition containing hemp seed oil and kenaf seed oil,
Mixing 40 to 60% by weight of mulberry leaves pulverized to 40 to 60% by weight of water and heating at 70 to 80 캜 for 4 to 6 hours to prepare a mulberry leaf concentrate;
Preparing hemp seed oil, kenaf seed oil, and Himalaya clay;
Mixing the mulberry leaf concentrate and silage of Himalaya at a ratio of the same weight percentage at 40 to 50 캜,
40 to 60% by weight of the hemp seed oil, 30 to 50% by weight of kenaf seed oil, and 5 to 15% by weight of the neutralized silazilate of Himalaya, mixing at 40 to 50 캜 and stirring for 20 to 40 minutes , ≪ / RTI &
Wherein the milking process of the hemp seed oil and the kenaf seed oil is carried out by maintaining a temperature of 40 to 50 DEG C by applying a semiconductor cooling method to the breastpower enclosure.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170095579A KR101844849B1 (en) | 2017-07-27 | 2017-07-27 | composite composition containing hemp-seed oil and kenaf-seed oil and method for producing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170095579A KR101844849B1 (en) | 2017-07-27 | 2017-07-27 | composite composition containing hemp-seed oil and kenaf-seed oil and method for producing |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101844849B1 true KR101844849B1 (en) | 2018-04-04 |
Family
ID=61975515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170095579A Expired - Fee Related KR101844849B1 (en) | 2017-07-27 | 2017-07-27 | composite composition containing hemp-seed oil and kenaf-seed oil and method for producing |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101844849B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200142720A (en) * | 2019-06-13 | 2020-12-23 | 이영기 | Laver snack including hemp seed powder and hemp oil, and manufacturing method and apparatus thereof |
KR20210140845A (en) | 2020-05-14 | 2021-11-23 | 주식회사 아이코맥스 | A skin cosmetic composition comprising goat's milk, hemp seed oil, manuca oil, Oenothera odorata oil and boswellia extract and the manufacuring method thereof |
KR20220133136A (en) * | 2021-03-24 | 2022-10-04 | 안보라미 | Composition for improving acne skin comprising hemp seed extract and hemp seed oil |
KR20230021820A (en) * | 2021-08-06 | 2023-02-14 | 문외숙 | Method for manufacturing hemp seed oil forming skin protective film and hemp seed oil composition comprising same |
WO2025033647A1 (en) * | 2023-08-07 | 2025-02-13 | 주식회사 한국인삼공사 | Composition for preventing, improving, or treating prostate disease, comprising hemp seed oil |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440436B1 (en) | 2001-05-18 | 2002-08-27 | Natreon Inc. | Process for preparing purified shilajit composition from native shilajit |
KR100861587B1 (en) * | 2008-02-15 | 2008-10-07 | 김미선 | Cosmetic or cleaning composition using hemp seed oil and method for preparing same |
-
2017
- 2017-07-27 KR KR1020170095579A patent/KR101844849B1/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440436B1 (en) | 2001-05-18 | 2002-08-27 | Natreon Inc. | Process for preparing purified shilajit composition from native shilajit |
KR100861587B1 (en) * | 2008-02-15 | 2008-10-07 | 김미선 | Cosmetic or cleaning composition using hemp seed oil and method for preparing same |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200142720A (en) * | 2019-06-13 | 2020-12-23 | 이영기 | Laver snack including hemp seed powder and hemp oil, and manufacturing method and apparatus thereof |
KR102220871B1 (en) * | 2019-06-13 | 2021-02-25 | 이영기 | Laver snack including hemp seed powder and hemp oil, and manufacturing method and apparatus thereof |
US11178887B2 (en) * | 2019-06-13 | 2021-11-23 | Young-Kee LEE | Laver snack including hemp seed powder and hemp oil, and manufacturing method and apparatus thereof |
KR20210140845A (en) | 2020-05-14 | 2021-11-23 | 주식회사 아이코맥스 | A skin cosmetic composition comprising goat's milk, hemp seed oil, manuca oil, Oenothera odorata oil and boswellia extract and the manufacuring method thereof |
KR20220133136A (en) * | 2021-03-24 | 2022-10-04 | 안보라미 | Composition for improving acne skin comprising hemp seed extract and hemp seed oil |
KR102675013B1 (en) * | 2021-03-24 | 2024-06-13 | 안보라미 | Composition for improving acne skin comprising hemp seed extract and hemp seed oil |
KR20230021820A (en) * | 2021-08-06 | 2023-02-14 | 문외숙 | Method for manufacturing hemp seed oil forming skin protective film and hemp seed oil composition comprising same |
KR102611676B1 (en) | 2021-08-06 | 2023-12-07 | 문외숙 | Method for manufacturing hemp seed oil forming skin protective film and hemp seed oil composition comprising same |
WO2025033647A1 (en) * | 2023-08-07 | 2025-02-13 | 주식회사 한국인삼공사 | Composition for preventing, improving, or treating prostate disease, comprising hemp seed oil |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101844849B1 (en) | composite composition containing hemp-seed oil and kenaf-seed oil and method for producing | |
Asadi-Samani et al. | The chemical composition, botanical characteristic and biological activities of Borago officinalis: a review | |
US8668944B2 (en) | Topical oil for treating physical ailments and method for making and applying the same | |
CN105685869A (en) | Dragon fruit stem chewable tablets and preparation method thereof | |
KR101716763B1 (en) | Breeding Method for Crickets Comprising Ginsenoside Type Saponin and Polysaccharide from Panax ginseng and their Extracts and Food Composition | |
KR20080079743A (en) | Method of manufacturing fermented products using wild grasses having a therapeutic effect on atopic dermatitis | |
KR101895521B1 (en) | method for manufacturing vinegar using Cudrania tricuspidata | |
KR100894636B1 (en) | Manufacturing method of beverage containing round hemp extract | |
KR101512230B1 (en) | Arthritis Remedy Composition and manufacture method having immunity and the circulation of the blood improvement fuction | |
Johar et al. | Mahua: A versatile Indian tree species | |
KR20030091616A (en) | Manufacture of a substance for improving bone density | |
CN114796070A (en) | Anti-inflammatory and antiallergic wound healing flower composition with repairing function and preparation method thereof | |
KR102347923B1 (en) | Extract of chicken comprising ginseng and preparation method of thereof | |
Dharmananda | Sea buckthorn | |
CN113040177A (en) | Plant fermentation extract for degrading pesticide residues of crops and preparation method thereof | |
KR20230052800A (en) | Health functional food composition for improvement of bowel function and relief of contipation comprising psyllium husk and complex extract, and manufacturing method thereof | |
KR20020029412A (en) | The health food and a manufacturing process of ones have effict a white hair turns black. | |
KR101129685B1 (en) | The Salicomia Herbaceal for the Atopic Dermatitis and the Method for Manufacturing Salicomia Herbaceal for the Atopic Dermatitis | |
CN107875059B (en) | Composition with acne removing effect | |
CN107822979B (en) | Preparation method of freeze-dried powder of composition with acne removing effect | |
KR20160107002A (en) | A method for preparing composition with flexseed | |
CN111012858A (en) | High-efficiency burn and scald medicine and preparation method thereof | |
KR102690689B1 (en) | Health supplement food comprising deer velvet extract for improving joint inflammation and method for manufacturing the same | |
KR102402980B1 (en) | Manufacturing method wood-cultivated ginseng gel | |
Ullah | MORINGA (Moringa oleifera) Cultivation Awareness in Pakistan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20170727 |
|
PA0201 | Request for examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20170727 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170920 Patent event code: PE09021S01D |
|
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20171229 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20180328 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20180329 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20210315 Start annual number: 4 End annual number: 4 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20230108 |